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ABSTRACT
The pluripotency factor Lin28 is a highly conserved
protein comprising a unique combination of RNA-
binding motifs, an N-terminal cold-shock domain
and a C-terminal region containing two retroviral-
type CCHC zinc-binding domains. An important
function of Lin28 is to inhibit the biogenesis of the
let-7 family of microRNAs through a direct inter-
action with let-7 precursors. Here, we systematically
characterize the determinants of the interaction
between Lin28 and pre-let-7g by investigating the
effect of protein and RNA mutations on in vitro
binding. We determine that Lin28 binds with high
affinity to the extended loop of pre-let-7g and that
its C-terminal domain contributes predominantly to
the affinity of this interaction. We uncover remark-
able similarities between this C-terminal domain
and the NCp7 protein of HIV-1, not only in terms of
primary structure but also in their modes of RNA
binding. This NCp7-like domain of Lin28 recognizes
a G-rich bulge within pre-let-7g, which is adjacent to
one of the Dicer cleavage sites. We hypothesize that
the NCp7-like domain initiates RNA binding and par-
tially unfolds the RNA. This partial unfolding would
then enable multiple copies of Lin28 to bind the
extended loop of pre-let-7g and protect the RNA
from cleavage by the pre-microRNA processing
enzyme Dicer.
INTRODUCTION
MicroRNAs (miRNAs) are short single-stranded RNAs
of  22nt found in virus, plant and animal species
that act as post-transcriptional regulators of mRNA ex-
pression [for recent reviews, see (1–4)]. They are generated
from a longer RNA, the primary transcript (pri-miRNA),
by a multi-step process. The pri-miRNA is ﬁrst cleaved by
the microprocessor complex containing the endonuclease
Drosha and the double-stranded RNA-binding protein
DGCR8 to produce a 60–70 nts RNA hairpin known as
the precursor miRNA (pre-miRNA). After being exported
to the cytoplasm, the pre-miRNA is further cleaved by the
endonuclease Dicer to form a  22-nt dsRNA. The single-
stranded mature miRNA is then loaded into the RNA-
induced silencing complex to regulate its target mRNAs.
miRNAs play important roles in cell differentiation (5–7),
and, in mammals, several miRNAs have been shown to
act as oncogenes and tumor suppressors [reviewed in (8–13)].
Among those playing a role as tumor suppressors, the
let-7 family of miRNAs have been extensively chara-
cterized, and are known inhibitors of oncogenes such as
RAS, MYC, HMGA2, and cyclin D1 (10). The let-7
miRNAs are often present in multiple copies in a single
genome, with the mature let-7 being highly conserved
across species. In human and mouse, there are 10
mature let-7 family sequences (let-7a, let-7b, etc.)
produced from 13 precursors.
Although levels of let-7 pri-miRNAs are controlled by
transcription factors, post-transcriptional regulation is
critical in determining the levels of mature let-7 miRNAs
(14–18). Recent studies in embryonic cells have high-
lighted the importance of Lin28 in post-transcriptional
regulation of the let-7 family of miRNAs, where it
acts as a selective inhibitor of let-7 miRNAs maturation
(19–21). The various members of the let-7 family are not
affected to the same degree by Lin28, with let-7a, let-7d
and let-7g being among the most affected. Several mech-
anisms have been proposed to explain the Lin28 inhibition
of let-7 biogenesis. Lin28 was shown to interfere with the
Drosha cleavage of pri-let-7 (16,19,21) and with the
cleavage of pre-let-7 by Dicer (22,23). In addition, Lin28
was shown to induce the uridylylation of pre-let-7 by the
recruitment of TUT4 (Zcchc11), which leads to its
*To whom correspondence should be addressed. Tel: 514 343 7326; Fax: 514 343 2210; Email: pascale.legault@umontreal.ca
Published online 19 October 2011 Nucleic Acids Research, 2012, Vol. 40, No. 4 1767–1777
doi:10.1093/nar/gkr808
 The Author(s) 2011. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.degradation (22,24–26). Although the relative importance
of these mechanisms in vivo has not been clearly established
(27), they all involve the formation of a complex between
Lin28 and the immature forms of the let-7 miRNA.
Lin28 is a highly conserved protein of 209 amino acids
known to be an important pluripotency factor (28), and its
role in pluripotency is likely related to its function in let-7
biogenesis (19,29). Lin28 contains a unique set of
RNA-binding motifs (30,31); an N-terminal cold shock
domain (CSD) and a C-terminal region composed of
two CCHC-type zinc-binding domains [ZBDs; (30)].
CSDs are found in several RNA- and DNA-binding
proteins (32), whereas the CCHC-type ZBDs are most
commonly found in retroviral nucleocapsid proteins,
such as the NCp7 protein from HIV-1 (33). Although
Lin28 has been shown to regulate the stability and trans-
lation of selected mRNAs (34–37), it plays a central role in
regulating levels of mature let-7.
Several in vivo and in vitro studies have sought to char-
acterize the interaction between pre-let-7 and Lin28
(19,20,23,24,38). It was demonstrated that both the CSD
and the ZBDs of Lin28 are necessary for pre-let-7g
binding in vitro and maturation inhibition in vivo (20).
As determined by in vitro binding assays, Lin28 binds
the extended terminal loop of pre-let-7g (20,38).
Mutation of a conserved cytosine in this loop was
shown to reduced its in vitro afﬁnity for Lin28 (20). A
G-rich sequence at the 50-end of the pre-let-7g terminal
loop was found to be strongly protected from ribonuclease
cleavage by Lin28 (38). In addition, mutations of a few
conserved nucleotides in the terminal loop make the
immature miRNA resistant to Lin28 inhibition in P19 em-
bryonal carcinona extract (19). Lin28 also binds the
extended terminal loop of pre-let-7a-2, and the sequence
composing the mature miRNA (let-7a) can compete with
pre-let-7a-2 binding for Lin28 (23). Moreover, a
four-nucleotide 50-GGAG-3’ sequence important for
Lin28 binding and its uridylylation by Zcchc11 was identi-
ﬁed at the 30-end of the terminal loop region of
pre-let-7a-1 (24). Although several studies have con-
tributed to establish that the RNA-binding domains of
Lin28 are important for recognition of the extended ter-
minal loop of pre-let-7, the key determinants of this inter-
action have not been systematically deﬁned.
In this work, we used electrophoretic mobility shift assay
(EMSA), ribonuclease protection assay, in-line probing
and NMR spectroscopy with puriﬁed molecules to map
the interaction between the pre-let-7g RNA and the Lin28
protein from mouse. We determine that the C-terminal
domain of Lin28 contributes predominantly to the high-
afﬁnity interaction with pre-let-7g and its sequence is very
similar to the NCp7 protein of HIV-1. We also uncover
several similarities in terms of RNA binding between
NCp7 and the C-terminal domain of Lin28.
MATERIALS AND METHODS
Plasmids
Lin28 expression vectors are derived from pGEX4T (GE
Healthcare) and were constructed using the Lin28 cDNA
from Mus musculus (Open Biosystems BC068304). Vectors
for RNA transcription were derived either from the
pARiBo1 plasmid or the pRSA-VS plasmid (39).
Mutant vectors were prepared using the Strategene
QuikChangeII site-directed mutagenesis method or by
standard cloning of restriction fragments. All plasmids
created for this study were veriﬁed by DNA sequencing.
RNA preparation for biochemical characterization and
NMR studies
Most RNAs used here were transcribed in vitro as ARiBo-
tagged precursors and puriﬁed by batch afﬁnity puriﬁca-
tion (39,40). In one case (TL-let-7g), the RNA was
synthesized in vitro as a precursor with a VS ribozyme sub-
strate at its 30-end and puriﬁed as described previously (41).
For biochemical characterization (gel-shift, footprinting
and in-line probing), the RNAs were [50-
32P]-labeled and
further puriﬁed by 20% denaturing gel electrophoresis
(42). For NMR studies, the RNAs were concentrated
and exchanged with an Amicon Ultra-15 3000 NMWL
(Millipore) in NMR buffer (10mM d18-HEPES at pH
6.4, 50mM NaCl, 0.05mM NaN3 and 10% D2O).
Protein expression and puriﬁcation for biochemical
characterization
Lin28 and related mutants were expressed in Escherichia
coli strain BL21 cells (Stratagene). The bacterial cultures
were grown in LB medium at 37 C and induced with
1mM isopropyl-b-D-thiogalactopyranoside (IPTG) for
4h at 30 C. The cells were harvested by centrifugation
and resuspended in binding buffer [25 mM Tris, pH 8.0,
1M NaCl, 0.1% NP-40 alternative (Calbiochem) and
1mM DTT] supplemented with Complete EDTA-free
protease inhibitor (Roche) and 10 U/ml of DNase I re-
combinant RNase-free (Roche). The cells were lysed by
French press and centrifuged at 100000g for 1h at 4 C.
The supernatant was incubated for 1h at 4 C with GSH-
Sepharose 4B resin (GE Healthcare). After incubation, the
resin was washed three times with the binding buffer and
three times with the S7 buffer (50mM Tris, pH 8.0, 50mM
NaCl, 5mM CaCl2 and 1mM DTT). The washed resin
was resuspended in S7 buffer and incubated overnight at
room temperature with 5U/ml of Nuclease S7 (Roche).
The resin was subsequently washed three times with S7
buffer and incubated 1h at room temperature with
100U of thrombin (Calbiochem). The eluted protein was
dialyzed 4h at 4 C in 2 l of 20mM Tris, pH 8.0, 2 M
NaCl, 1mM DTT and overnight at 4 C in 20mM Tris,
pH 8.0, 1M urea, 200mM NaCl and 1mM DTT. The
dialyzed protein was loaded on an SP-Sepharose
high-performance column (GE Healthcare) equilibrated
with FPLC-A (20mM Tris, pH 8.0 and 1mM DTT).
The protein was eluted from the column using a
gradient (from 0% to 100% over 525mL) of FPLC-B
(20mM Tris, pH 8.0, 2 M NaCl and 1mM DTT). The
fractions containing the protein were combined,
concentrated with an Amicon Ultra-15 3000 NMWL
(Millipore) and dialyzed in storage buffer (100mM Tris,
pH 7.6, 100mM NaCl, 20% glycerol and 2mM DTT).
The NCp7 protein was expressed and puriﬁed as described
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veriﬁed by mass spectrometry.
Protein expression and puriﬁcation for NMR studies
For NMR studies, uniform
15N- and
15N/
13C labeling was
obtained by growing the cells in minimal media containing
15N-labeled NH4Cl and
13C6-glucose as the sole sources
of nitrogen and carbon, respectively. Protein puriﬁcation
was conducted as described above, but with the following
modiﬁcations. The selected fractions from the SP-
Sepharose column were dialyzed in 5% acetic acid, con-
centrated on a rotary evaporator and puriﬁed on a Vydac
C4 reverse-phase HPLC column using an acetonitrile
gradient (from 15% to 35% over 335ml) in 0.05% TFA.
After HPLC puriﬁcation, the proteins were refolded in the
presence of zinc, as described previously (44).
Electrophoretic mobility shift assay
For EMSA, the
32P-labeled RNA was ﬁrst heated and
snap cooled (heated 2min at 95 C and snap-cooled on
ice for 5min) to promote hairpin formation. The protein
samples were diluted in EMSA buffer (50mM Tris, pH
7.6, 50mM NaCl, 10% glycerol, 0.05% NP-40 alternative
and 2mM DTT) and their concentrations were adjusted to
span from 0.02  to 50  of the estimated Kd. The binding
reactions (20ml) were initiated by mixing 1pM
of
32P-labeled RNA with the diluted proteins and
incubated at 4 C for 30min. For each Kd determination,
 14 binding reactions were loaded directly on an 8%
native polyacrylamide gel (37.5:1 polyacrylamide/
bisacrylamide) and run in Tris–Glycine buffer (25mM
Tris–Base and 200mM glycine) at 200V for 2h with
active water cooling in the cold room. The gels were
ﬁxed in 50% methanol and 10% acetic acid for 1h,
washed 15min in 30% ethanol, quickly rinsed with H2O
and exposed overnight to a storage phosphor screen
(Bio-Rad). The
32P-labeled RNA was visualized with a
Bio-Rad Molecular Imager FX densitometer, and band
intensities were quantiﬁed using the QuantityOne
software (version 4.6.6 from Bio-Rad). The fraction of
bound RNA was plotted against protein concentration,
and the data were ﬁtted to the one-site binding equation
or to the Hill equation (only for the two cases in Table 1)
by nonlinear regression analysis within the Origin 7 SR4
version 7.0552 software (OriginLab, MA, USA). For each
protein–RNA complex, at least three independent Kd de-
termination experiments were performed. The reported
Kd’s and their errors are, respectively, the average values
and the standard deviations from these multiple
experiments.
In-line probing assay
In-line probing assays were performed as described previ-
ously (45). The
32P-labeled RNA was visualized with a
Bio-Rad Molecular Imager FX densitometer, and band
intensities were quantiﬁed using the Image Lab software
(version 3.0 from Bio-Rad).
RNA footprinting assay
For RNase footprinting, the
32P-labeled RNA was ﬁrst
heated and snap cooled to promote hairpin formation.
The Lin28119–180 protein was diluted at various concentra-
tions in EMSA buffer. The protein was ﬁrst incubated
with 1nM of
32P-labeled RNA (10ml total volume) for
30min at 4 C. Then, 1U of T1 ribonuclease from
Aspergillus oryzae (Sigma) was added and the incubation
continued for 15min at 4 C. The reaction was stopped
by the addition of Precipitation/Inactivation buffer
(Ambion), incubation for 15min at  20 C and centrifu-
gation at 16000g for 15min. The RNA pellet was
dissolved in Gel loading buffer II (Ambion), loaded on a
20% polyacrylamide/7 M urea sequencing gel and run at
1900V for 5h. The sequencing gel was exposed 2h to a
storage phosphor screen (Bio-Rad). The
32P-labeled RNA
bands were visualized and quantiﬁed as for the EMSA
assay.
NMR Spectroscopy
For NMR studies, the following samples were prepared
in NMR buffer: 1.0mM
15N-labeled Lin28136–180;
1.3mM
15N-labeled Lin28119–180; 1.1mM
13C/
15N-labeled
Lin28119–180; 0.1mM TL-let-7g:
15N-labeled Lin28119–180;
0.1mM bulge TL-let-7g:
15N-labeled Lin28119–180;0 . 1 m M
G34AG35A TL-let-7g:
15N-labeled Lin28119–180; 1.0mM
TL-let-7g:
15N-labeled Lin28119–180; and 1.3mM TL-let-
7g:
13C/
15N-labeled Lin28119–180. For the TL-let-7g:
Lin28119–180 complexes, the samples were prepared by ti-
tration of Lin28119–180 into a TL-let-7g sample. All NMR
experiments were collected on Varian
UnityINOVA 500
and 600MHz spectrometers equipped with a pulse-ﬁeld
gradient unit and an actively shielded z gradient probe
(either a room-temperature probe or a cryogenic probe).
The backbone resonances (
1H,
15N and
13C) of Lin28119–
180 in the free and TL-let-7g-bound form were assigned
using the following NMR experiments collected at 35 C:
two-dimensional (2D)
1H-
15N HSQC (46); three-
dimensional (3D) HNCACB (47–49); and 3D
(HB)CBCA(CO)NNH (48,49).
1H,
13C and
15N chemical
shifts were referenced to an external standard of 2,2-
dimethyl-2-silapentane-5-sulfonic acid (DSS) at 0.00ppm
(50). NMR data were processed with NMRPipe/
NMRDraw (51) and analyzed with NMRView (52).
RESULTS
Lin28 recognizes the terminal loop of pre-let-7g with its
C-terminal domain providing the most important energetic
contribution
To identify the domain(s) of Lin28 important for binding
the let-7g precursor miRNA (pre-let-7g), we used EMSAs
with puriﬁed recombinant proteins and in vitro transcribed
RNAs (Figure 1). It was previously established that Lin28
recognizes pre-let-7g and its terminal loop with a similar
afﬁnity [Kd of 1–2mM; (20,38)]. Thus, we initiated our
study by determining the Kd of full-length Lin28
(Lin281–209) for the terminal loop of pre-let-7g (TL-let-7g;
Figure 1D). We attempted to ﬁt the data (Figure 2A)
Nucleic Acids Research,2012, Vol.40, No. 4 1769using the classical one-site binding equation, but the ﬁt
was rather poor (Figure 2C, red line). Using the Hill
equation, a much better ﬁt was obtained (Figure 2C,
blue line), from which we derived a Kd of 0.13±
0.02nM with a Hill coefﬁcient of 2.9±0.7 (Table 1).
These results clearly demonstrate that Lin28 binds the
terminal loop of pre-let-7g with much higher afﬁnity
than previously reported (20,38).
Given this unexpected result, we veriﬁed the binding of
Lin28 to the full-length pre-let-7g. We obtained a Kd of
0.15±0.04nM with a Hill coefﬁcient of 2.7±0.5 for this
interaction (Table 1), conﬁrming that pre-let-7g and its
terminal loop have similar afﬁnities for Lin28, as previ-
ously established (20,38). As a control, we measured
the binding for Lin28 to an RNA that contains only
the miRNA stem of pre-let-7g (duplex let-7g GNRA;
Figure 1C) and obtained a 60-fold lower Kd (Kd=9±
3nM), further supporting that the terminal loop is the
main determinant of Lin28 binding to pre-let-7g.
Since Lin28 contains two different RNA-binding
domains, we determined the afﬁnity of Lin28 fragments
containing either the CSD (Lin2839–112) or the two ZBDs
(Lin28119–180) for pre-let-7g, TL-let-7g and duplex let-7g
GNRA (Figure 1). For the N-terminal Lin2839–112
fragment comprising the CSD (Figure 1A), Kd values of
41±10nM and 126±41nM were obtained for pre-let-7g
and TL-let-7g, respectively, indicating signiﬁcantly weaker
afﬁnity (<250-fold) compared to the full protein. For the
duplex let-7g GNRA, only a minimum Kd value could be
obtained (>250nM), because of aggregation of the
Lin2839–112 domain detected at concentrations higher
than 250nM. In contrast, the Lin28119–180 fragment con-
taining the ZBDs displays only slightly lower afﬁnities
than full-length Lin28 toward pre-let-7g and TL-let-7g,
with Kd values of 0.6±0.1nM and 1.3±0.3nM, respect-
ively (Table 1, Figure 2B and C). These binding data for
Lin28119–180 can be ﬁtted to a classical one-site binding
equation (Figure 2C and Table 1). For the duplex-let-7g
GNRA, no speciﬁc binding could be observed with
Lin28119–180. Thus, compared to the full-length protein,
the C-terminal Lin28119–180 fragment containing the two
ZBDs displays similar speciﬁcity toward RNAs derived
from pre-let-7g. Furthermore, the afﬁnity between
Lin28119–180 and TL-let-7g is only 10-fold weaker than
between the full-length Lin28 protein and pre-let-7g,
indicating that Lin28119–180 and TL-let-7g encompass the
main determinants of the Lin28/pre-let-7g interaction.
Similarities between the C-terminal domain of Lin28 and
the HIV-1 NCp7 protein
It has been previously noted that the C-terminal domain
of Lin28 contains two ZBDs similar to those found in viral
nucleocapsid proteins (30). Given the importance of this
RNA-binding domain for pre-let-7g binding, we searched
for proteins containing a similar domain in the Swiss-Prot
database using BLAST (53). The nucleocapsid proteins
from simian and human immunodeﬁciency viruses give
the highest scores after Lin28 proteins from different
species. The sequence alignment between the well-
characterized HIV-1 nucleocapsid NCp7 and metazoan
Lin28 sequences indicates signiﬁcant similarities in the
ZBDs, and also, surprisingly, in the N-terminal KR-rich
domain (Figure 3). The percentage of sequence similarity
to HIV-1 NCp7 is relatively high for both murine (45%)
and human Lin28123–180 (45%). All three proteins contain
identical zinc-chelating amino acids (CCHC) and spacing
between these residues in the two ZBDs. In addition, the
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Figure 1. The Lin28 protein, pre-let-7g RNA and related sequences used in this study. (A) Schematic representation of the primary structures of
Lin28 and deletion fragments. The gray boxes delineate sequences of known RNA-binding motifs: a cold shock domain (CSD) and a pair of
retroviral–type CCHC zinc-binding domains (ZBD1 and ZBD2). (B) Schematic representation of pre-let-7g, indicating the regions (gray boxes) from
which TL-let-7g and duplex let-7g GNRA were derived. (C and D) Primary and secondary structures of the (C) duplex let-7g GNRA and (D) TL-let-
7g. Nucleotides within the mature miRNA sequence are in blue and non-natural nucleotides are shown in lowercase. In (D), site-speciﬁc mutations of
TL-let-7g are in red and regions that were replaced by alternative structured elements are boxed.
1770 Nucleic Acids Research, 2012,Vol.40, No. 4spacing between the two ZBDs is similar with seven resi-
dues in NCp7 of HIV-1 and eight residues in the Lin28
sequences (Figure 3). Furthermore, this sequence
similarity also involves several of the NCp7 residues
from the KR-rich domain and the two ZBDs that contrib-
ute to the RNA-binding interface as observed in the NMR
structures of RNA/NCp7 complexes (33,54).
To further investigate the binding of Lin28119–180 to
TL-let-7g, we performed NMR chemical shift perturb-
ation experiments. In both the free and bound forms,
Lin28119–180 displays a well-dispersed
1H-
15N HSQC
spectrum (Figure 4A), indicating that both adopt a
stable homogenous conformation in solution. Analysis
of the
1H and
15N chemical shifts reveals that 21 of the
56 amino acid residues analyzed display signiﬁcant chem-
ical shift differences between the free and RNA-bound
form (Figure 4B; d>0.4ppm). When mapped onto the
primary structure of Lin28119–180, the residues showing
signiﬁcant chemical shift differences are found in the
KR-rich domain, both ZBDs, as well as in the linker be-
tween ZBD1 and ZBD2. These results indicate that all
these domains participate in RNA binding either by
direct contact or through conformational rearrangement
of the protein.
To determine if the Lin28119–180 fragment could be
shortened while maintaining its afﬁnity for the terminal
loop of pre-let-7g, we generated several N-terminal and
C-terminal deletions (Figure 1A). Of the three deletion
fragments that were expressed and puriﬁed (Lin28136–180,
Lin28119–140 and Lin28119–160), none binds TL-let-7g with
high afﬁnity (Kd>5mM; Table 2), and thus Lin28119–180
constitutes the minimal domain required for TL-let-7g
binding. It is particularly striking that removal of the
ﬁrst 17 amino acids encompassing the KR-rich domain
is as detrimental to binding as removal of one or two
ZBDs. To insure that the absence of binding with
Lin28136–180 is not due to protein misfolding, we compared
the
1H-
15N HSQC spectrum of this fragment with that of
Lin28119–180 (Supplementary Figure S1). The chemical
shift similarity between these two spectra indicates that
the ZBDs adopt a similar fold in Lin28136–180 and
Lin28119–180. In addition, the importance of the KR-rich
domain was further investigated using a mutant of
Lin28119–180 in which all lysines and arginines of the
KR-rich domain are mutated (KR
- with mutations
R122A, R123A, K125A, K127A, K131A, R132A,
R133A and K135G). As expected, Lin28119–180 (KR
 )
does not bind TL-let-7g with high afﬁnity (Kd>5mM;
Table 2). Interestingly, we found that the NCp7 protein of
HIV-1 binds with the same afﬁnity to TL-let-7g
(1.1±0.3nM) as Lin28119–180 (Table 2). Thus, in addition
to sharing sequence similarity with NCp7, Lin28119–180
also uses both its KR-rich and ZBDs for RNA recog-
nition and binds with the same afﬁnity as NCp7 to
TL-let-7g. To emphasize these similarities with
NCp7, we deﬁned Lin28119–180 as the NCp7-like domain
of Lin28.
Global mapping of the interaction site using ribonuclease
protection assay
A ribonuclease protection assay was used to identify the
region(s) of TL-let-7g interacting with the NCp7-like
domain. As a ﬁrst step, in-line probing (Supplementary
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Figure 2. EMSA of TL-let-7g with Lin281–209 and Lin28119–180.
(A) Typical EMSA performed with 1 pM of 50-[
32P]-labeled TL-let-7g
and increasing concentrations of Lin281–209 (0.0, 0.002, 0.010, 0.025,
0.050, 0.075, 0.10, 0.15, 0.20, 0.50, 1.0, 2.5 and 5.0nM). (B) Typical
EMSA for TL-let-7g and increasing concentrations of Lin28119–180 (0.0,
0.02, 0.10, 0.25, 0.50, 0.75, 1.0, 1.25, 1.5, 1.75, 2.0, 5.0,10, 25 and
50nM). (C) The bound fraction of RNA is plotted against the total
concentration of protein. The data for binding of TL-let-7g to
Lin281–209 (squares) are ﬁtted to both the one site binding equation
(red line; Kd=0.2nM) and the Hill equation (blue line; Kd=
0.13nM). The data for binding of TL-let-7g to Lin28119–180 (dots)
are ﬁtted to the one site binding equation (green line; Kd=1.3nM).
Table 1. Dissociation constants (Kd innM) of different domains of
Lin28 for various pre-let-7g constructs
RNA Lin281–209 Lin2839–112 Lin28119–180
Pre-let-7g 0.15±0.04 41±10 0.6±0.1
n=2.7±0.5
a
Duplex let-7g GNRA 9±3 >200 n.b.
b
TL-let-7g 0.13±0.02 126±41 1.3±0.3
n=2.9±0.7
a
aIn these cases, the Hill equation was used to derived the Kd values.
bNo speciﬁc binding observed. The gel mobility shift assays display
smearing and multiple shifts, indicating non-speciﬁc binding.
Nucleic Acids Research,2012, Vol.40, No. 4 1771Figure S2) was performed to establish the secondary struc-
ture of TL-let-7g. These results conﬁrm that the free
TL-let-7g adopts a hairpin conformation, with dynamic
residues in the G-rich bulge (residues 7–11), the adjoining
internal loop (residues 16–19 and 32–35) and the hairpin
loop (residues 24–27; Figure 5A). For the ribonuclease
protection assay, RNase T1 was selected because it
shares the speciﬁcity of ZBDs for single-stranded guanines
(55). The results of nuclease mapping in the presence of
increasing concentration of Lin28119–180 (Figure 5) clearly
demonstrate that only the G residues within the G-rich
bulge (G8, G10 and G11) and adjacent stems (G4 and
G12) are protected by Lin28119–180. Only one G residue
(G18) becomes more accessible in the presence of
Lin28119–180, most likely resulting from destabilization of
the predicted G18–C12 base pair (see Discussion section).
Thus, the ribonuclease protection assay indicates that the
G-rich bulge is the main binding site for the NCp7-like
domain and that the adjoining internal loop is also
affected by binding.
Detailed mapping of the pre-let-7g determinants for
Lin28119–180 binding
Next, we performed an exhaustive EMSA analysis of
TL-let-7g mutants to identify the RNA determinants of
the high-afﬁnity interaction between TL-let-7g and
Lin28119–180 (Kd=1.3nM; Table 3). Since NCp7 and
several other ZBDs speciﬁcally recognize single-stranded
nucleic acids (33,54), several mutants of the loop regions
of TL-let-7g (Figure 1D) were investigated. Replacement
of the ACCC hairpin loop by a stable GNRA tetraloop
(GCAA) increases the Kd by a factor of 3, and the
punctual C25A mutation increases the Kd by a factor of
1.6. Deletion of unpaired nucleotides in the internal loop
to create a stable stem (Figure 1D; iloop) causes a
5.3-fold increase in the Kd compared with the wild-type
A
B
Figure 4. (A) Superposition of 2D
1H-
15N HSQC spectra of 1mM
13C/
15N-labeled Lin28119–180 in the free form (black) and bound to
1mM TL-let-7g (red). The signals from the free form that display a
signiﬁcant chemical shift change (d>0.4ppm) as a result of RNA
binding are annotated and the change is illustrated with an arrow. A
very weak signal for D137 in the complex is indicated by a star.
(B) Histogram displaying the differences in chemical shifts (d in
ppm±0.03ppm) observed after the addition of a molar equivalent of
TL-let-7g to 1mM
13C/
15N-labeled Lin28119–180. The chemical shift
differences (d) were calculated according to the formula
d=[(H
N)
2+(0.17N
H)
2]
1/2.
3                   11 13                                 30          35                                51
HIV-1 NCp7 ZBD1 ZBD2 KR-rich
Figure 3. Sequence similarity between the HIV-1 NCp7 and the C-terminal domain of Lin28. The sequences of HIV-1 NCp7 and Lin28 from Mus
musculus (mmu), Homo sapiens (hsa), Gallus gallus (gga), Xenopus laevis (xla) and Danio rerio (dre) were aligned using ClustalW2 (70). A consensus
sequence is given with the standard one-letter code in capital letters for amino acids, as well as the following notation: a, aromatic; h, hydrophobic;
p, polar; +, positively charged. The schematic representation of NCp7 highlights the domains that contribute to RNA binding: an N-terminal
KR-rich domain and two zinc-binding domains (ZBD1 and ZBD2). The residues of NCp7 in red and blue make direct contact with zinc and RNA,
respectively (33,54). Those residues that could play an equivalent role in Lin28 are similarly colored.
Table 2. Dissociation constants (Kd innM) of mutants of the
NCp7-like domain of Lin28 (Lin28119–180) for the TL-let-7g RNA
Protein Kd (nM)
Lin28119–180 1.3±0.3
Lin28136–180 >5000
Lin28119–140 >2500
Lin28119–160 >5000
Lin28119–180 (KR
 ) >5000
HIV–1 NCp7 1.1±0.3
1772 Nucleic Acids Research, 2012,Vol.40, No. 4RNA. Similar changes in afﬁnity are also observed with
simultaneous mutations of three unpaired nucleotides
from the internal loop (A19C/G34A/G35A: 6.2-fold Kd
increase) or from the combined effect of two related mu-
tations (1.2- and 3.8-fold Kd increase for the A19C and
G34A/G35Amutants,respectively).Thus,theinternalloop
of TL-let-7g makes a minor contribution to Lin28119–180
binding, but the hairpin loop appears to be replaceable.
Several EMSA results indicate that the G-rich bulge
contributes signiﬁcantly to Lin28119–180 binding. First,
deletion of the G-rich bulge (Figure 1D; bulge) has a
substantial effect since no speciﬁc binding could be ob-
served with this mutant at a protein concentration as
high as 5mM. Similarly, no speciﬁc binding could be
observed for a mutant in which all guanines at the bulge
were mutated (G8C/G10C/G11A/G12A). To identify
the guanine residues of the G-rich bulge that are import-
ant for Lin28119–180 binding, each guanine was indi-
vidually mutated and the Kd was determined by EMSA
(Table 3). Although the G8C and G11A mutations have a
negligible effect on binding, the G10C or G12A mutations
cause 7- and 19-fold increases in Kd, respectively, which
represent the largest changes observed in this study for
single nucleotide mutations. Surprisingly, the double
G10C/G12A mutation does not completely abolish speciﬁc
binding, but instead has a similar effect on binding as the
single G12A mutation, suggesting that the remaining
guanine residues (G8 and G11) may contribute to binding
in the double mutant (G10C/G12A). Thus, it appears that
G10 and G12 are key residues for the recognition, but that
other G residues may also contribute to the afﬁnity of the
G-rich bulge for Lin28119–180. The G-rich bulge clearly
represents the main RNA determinant of the high-afﬁnity
interaction with Lin28119–180, although the internal loop of
TL-let-7g makes a minor contribution to binding.
To provide additional evidence for the importance of
the G-rich bulge, we performed NMR studies of Lin28119–
180 in complex with TL-let-7g mutants (Supplementary
Figure S3). As expected, the
1H-
15N HSQC spectrum of
the G34AG35A/Lin28119–180 complex is almost identical
to that of the TL-let-7g/Lin28119–180 complex, particularly
for residues from the two ZBDs. In contrast, the
1H-
15N
HSQC spectrum of the bulge/Lin28119–180 complex indi-
cates that, at the high concentration (0.1mM) used for
these NMR studies, Lin28119–180 interacts with the
bulge mutant, but in a different manner than observed
for the wild-type TL-let-7g. Thus, these NMR results
conﬁrm that the G-rich bulge is the main determinant
for high-afﬁnity binding of Lin28119–180 to TL-let-7g.
B
C
A
Figure 5. Footprint analysis of TL-let-7g with RNase T1.( A)
Secondary structure of TL-let-7g with the mapping of in-line probing
and T1 footprinting data. Residues that are the most susceptible to
spontaneous cleavage through in-line attack are in bold
(Supplementary Figure S2), and residues that experience a signiﬁcant
reduction (Ip/I0= 4) or enhancement (Ip/I0=+4) of T1 cleavage in
the presence of Lin28119–180 are shaded in red and blue, respectively. (B)
Typical RNA footprinting gel of TL-let-7g in the absence and presence
of Lin28119–180 (at concentrations of 0, 1, 5, 25, 100, 250, 500 and
1000nM). Lanes with input TL-let-7g (RNA), an alkaline hydroly-
sis ladder (OH ) and a T1 hydrolysis ladder (T1) are also included.
(C) Histogram of normalized band sensitivity (Ip/I0, where Ip and I0
are, respectively, the intensity in the presence and absence of protein)
for T1 cleaveage of each guanine obtained at 25–500nM Lin28119–180.
Table 3. Dissociation constants (Kd innM) of the NCp7-like domain
of Lin28 (Lin28119–180) for various mutants of the TL-let-7g RNA
TL-let-7g RNA Kd (nM) Kd/[Kd (wt)]
a
Wild type (wt) 1.3±0.3 1
GNRA tetraloop 4±1 3.1
C25A 2.1±0.5 1.6
iloop 6.9±0.7 5.3
A19C 1.6±0.6 1.2
G34A G35A 5±1 3.8
A19C G34A G35A 8±2 6.2
bulge n.b.
b n.b.
b
G8C G10C G11A G12A n.b.
b n.b.
b
G8C 1.1±0 1 0.9
G10C 9±2 6.9
G11A 3±1 2.3
G12A 25±7 19
G10C G12A 18±5 14
aThe Kd/[Kd (wt)] is the ratio of the Kd obtained for the mutant TL-let-
7g over the Kd obtained for the wild-type TL-let-7g RNA.
bNo speciﬁc binding observed. The gel mobility shift assays display
smearing and multiple shifts, indicating non-speciﬁc binding.
Nucleic Acids Research,2012, Vol.40, No. 4 1773Given the importance of the G-rich bulge for Lin28119–
180 binding, we examined the sequences of all known
pre-let-7g RNAs (Supplementary Figure S4). We ﬁnd
that the sequences of the G-rich bulge and adjacent
residues are highly conserved in mammals, birds and am-
phibians and ﬁt the consensus sequence U*AGGGU (* is
A, C or G), with the UGAGGGU sequence found in
mouse and human being the most common.
DISCUSSION
In this work, we systematically identiﬁed the key deter-
minants of the interaction between pre-let-7g and Lin28
using highly-puriﬁed proteins and RNAs. A surprising
result is the high afﬁnity (Kd of 0.15nM) measured for
Lin28 binding to pre-let-7g, given that a Kd of 1–2mM
has previously been reported for this interaction (20,38).
One important factor that may explain the higher afﬁnity
measured in this study is the absence of RNA competitor
in the binding buffer. We also took great care of removing
RNA contaminants during the puriﬁcation of the Lin28
proteins and found it necessary to use the S7 nuclease.
Nevertheless, our results are in general agreement with
previous studies, which established that the extended
terminal loop of pre-let-7g is the binding site for Lin28
(20,38).
The EMSA data for the binding of full-length Lin28 to
pre-let-7g and TL-let-7g could be ﬁtted well by using the
Hill equation, but not the classical one-site binding
equation (Figure 2C). The Hill coefﬁcients of  2.8
indicate that these interactions involve a minimum of
three binding sites for Lin28 on the target RNA, and
most likely reﬂect positive cooperativity for these
binding events (56). The concept that Lin28 can bind
multiple sites on the RNA is further supported by
supershifts observed at higher protein concentration
(>5nM; Figure 2A). Since the Hill coefﬁcients obtained
for TL-let-7g and pre-let-7g are essentially identical, we
propose that full-length Lin28 can cooperatively bind a
minimum of three sites in the extended terminal loop of
pre-let-7g. This ability of Lin28 to cooperatively bind
multiple sites is not observed with the isolated
NCp7-like domain and could not be identiﬁed from our
binding data with the isolated CSD due to severe aggre-
gation problems, as previously reported (31). The CSD of
Lin28 is similar to bacterial cold shock proteins (30), and
other members of this family of proteins are reported to
display cooperativity and weak speciﬁcity (57). For
example, the RNA chaperone CspA is known to destabil-
ize RNA secondary structure by cooperatively binding to
single-stranded regions with low sequence speciﬁcity (58).
Thus, although the CSD of Lin28 does not contribute
signiﬁcantly to the afﬁnity of Lin28 to pre-let-7g, it may
mediate cooperative binding in the context of the
full-length protein.
The C-terminal domain of Lin28 displays remarkable
similarities with the NCp7 protein of HIV-1. The
sequence alignment between the NCp7 protein and
metazoan Lin28 proteins shows a high degree of similar-
ity, which involves several residues from the KR-rich
domain and the two ZBDs of NCp7. Several of these
residues have been shown to contribute to RNA binding
in NMR structures of NCp7 bound to RNA hairpins
derived from the HIV-1  site (33,54). Here, both NMR
and mutational studies conﬁrmed that the KR-rich
domain and both ZBDs of Lin28 participate in TL-let-
7g binding. In particular, truncation of the KR-rich
domain or mutations of K/R residues within the
KR-rich domain of Lin28119–180 abrogate high-afﬁnity
binding to TL-let-7g. Similarly, truncation of the
KR-rich domain from HIV-1 NCp7 was previously shown
to prevent the speciﬁc binding of NCp7 to its -site RNA
target (59).
The similarity between Lin28119–180 and the NCp7
protein also extends to their binding afﬁnity and speciﬁ-
city. Indeed, both Lin28119–180 and NCp7 display low
nanomolar afﬁnities toward their speciﬁc RNA targets
(60,61) and speciﬁcally recognize a G-rich single-stranded
region. Furthermore, we ﬁnd that Lin28119–180 and NCp7
bind TL-let-7g with similar afﬁnities under the same con-
ditions. Lin28119–180 preferentially binds the G10-X-G12
unit of the G-rich bulge, but may also bind G8-X-X-G11
when G10 and G12 are simultaneously mutated. Our
results are compatible with a recent study in which
Lin28 was found to strongly protect residues G8, G10,
G11 and G12 of the G-rich bulge of pre-let-7g from ribo-
nuclease cleavage (38). The sequence at the G-rich bulge of
pre-let-7g is highly conserved in mammals (Supplementary
Figure S4), and sequence similarity was also found in this
region for most human and mouse let-7 family members
(19,20,24). Thus, it is likely that this region is important
for Lin28 binding to other pre-let-7 miRNAs. NCp7 from
HIV-1 was also reported to bind exposed guanines with its
two ZBDs (33,54,60,62,63). Its target sequences in the
-site RNA are generally located in a hairpin loop,
where they form a G-X-G motif, but exceptions such as
the binding to the 1 3 internal loop of SL1 demonstrate
ﬂexibility in RNA recognition by NCp7 (60,63). This ﬂexi-
bility in target sequence recognition may be inherent to the
adaptive nature of the NCp7 motif and may explain, in
part, why Lin28 binds a wide variety of mRNA targets in
addition to let-7 precursors (35,36,64,65). Lin28119–180
possibly recognizes its RNA target in the same way that
HIV-1 NCp7 binds hairpin loops in the HIV  RNA
(33,54). In this model, the two ZBDs of Lin28 would
each bind an exposed guanine in the G-rich bulge and
the KR-rich domain would bind an adjacent stem or
enlarged major groove. Interaction of Lin28119–180 with
a domain adjacent to the G-rich bulge is consistent with
our mutational studies, which indicate that the internal
loop of TL-let-7g makes a small contribution to binding.
Given all these similarities between NCp7 and Lin28119–
180, it is tempting to speculate on a role for HIV-1 NCp7 in
let-7 biogenesis and a common origin for NCp7 and the
C-terminal domain of Lin28. The latter is inconsistent
with a classical evolutionary model that does not include
viruses, but agrees with an alternative model in which
viruses play an important role in cellular evolution (66,67).
The high-afﬁnity of Lin28 toward TL-let-7g is mostly
due to its C-terminal NCp7-like domain, which has been
shown to be required for several functional aspects of
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inhibition of pre-let-7g in vivo (20), its localization to
P-bodies (31), its speciﬁc binding to let-7 precursors
(20,24) and for the Lin28-mediated uridylylation of
pre-let-7-a-1 by TUT4 (22). However, the NCp7-like
domain is not sufﬁcient for Lin28 function, as previously
demonstrated with two Lin28 homologs, Lin28B and
Lin28B-S, which are overexpressed in human
hepatocellular carcinoma and in several cancer lines (68).
The Lin28B-S preserves the NCp7-like domain but
contains a truncation of the cold-shock domain. It has
been shown that the overexpression of Lin28B-S does
not induce cancer cell proliferation in contrast to what is
observed with Lin28B (68). In addition, Lin28B-S does
not inhibit the processing of pri-let-7g like Lin28 and
Lin28B (21). Thus, although the NCp7-like domain of
Lin28 likely contributes to its in vivo function through
high-afﬁnity and speciﬁc binding to the terminal loop of
pre-let-7g, the cold-shock domain is required for Lin28 to
function as an effective oncogene and inhibitor of let-7
biogenesis.
Given its high-afﬁnity for pre-let-7g, the NCp7-like
domain may be responsible for the initial targeting of
pre-let-7g. After this initial binding event, partial unfold-
ing of the terminal loop of pre-let-7g would make it more
accessible for binding multiple copies of Lin28. Both the
NCp7 domain and the CSD have been previously
described as RNA chaperones (58,69) and could contrib-
ute to making the terminal loop more accessible. In agree-
ment with this role of the NCp7-like domain in Lin28, its
binding to TL-let-7g makes G18 of the internal loop more
accessible to ribonuclease cleavage. The high-afﬁnity and
speciﬁcity of the NCp7-like domain for the G-rich bulge
may also allow Lin28 to bind its RNA target in an orderly
fashion to insure that important functional regions of the
RNA are protected from binding of miRNA processing
enzymes. The G-rich bulge is directly adjacent to one of
the Dicer processing site. Thus, it is likely that Lin28
binding at the G-rich bulge protects the pre-let-7g RNA
from Dicer cleavage at this site, likely by both steric hin-
drance and destabilization of the stem region near the
G-rich bulge (38).
Our mutagenesis, T1 footprinting and NMR data all
indicate that the G-rich bulge of TL-let-7g is the main de-
terminant for high-afﬁnity binding to Lin28119–180.I na n
apparent contradiction with our results, a previous report
identiﬁed a different G-rich region of pre-let-7 (GGAG
residues 34–37 of the internal loop in Figure 5A) to be
important for Lin28 binding (24). Both these G-rich
regions are highly conserved in mammalian let-7g, and
similar G-rich regions are found both at the 50-end and
30-end of the terminal loop in most members of the human
and mouse let-7 family (19,20,24). Thus, it is likely that
both G-rich regions in pre-let-7 miRNAs are important
for binding full-length Lin28. For example, initial binding
of Lin28 to the G-rich bulge may expose internal loop
residues and allow Lin28 binding to the other G-rich
region. Alternatively, the levels of Lin28 and other cellular
factors may affect binding of Lin28 to the two G-rich
regions. Interestingly, both hnRNP A1 and KSRP specif-
ically bind G-rich sequences within the terminal loop of
pre-let-7a1 (17,18) and may regulate Lin28 binding at
these sites in some pre-let-7 members. Clearly, further
studies are needed to more precisely determine how each
G-rich region contributes with cellular factors to regulate
pre-let-7 biogenesis.
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